Potential conflicts of interest. J. M. S. reports consulting fees from AbbVie, Merck, Gilead Sciences, GSK, ViiV, Pfizer, Moderna, Teva, and Virology Education; payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing, or educational events from AbbVie, Merck, Gilead Sciences, GSK, ViiV, Pfizer, Moderna, Teva, and Virology Education; support for attending meetings and/or travel from AbbVie, Merck, Gilead Sciences, GSK, ViiV, Pfizer, Moderna, Teva, and Virology Education; participation on a data and safety monitoring board or advisory board for AbbVie, Merck, Gilead Sciences, GSK, ViiV, Pfizer, Moderna, Teva, and Virology Education; and an unpaid leadership or fiduciary role on the World Health Organization HIV Resistance Network. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.